| 2922.39.05 | 00 | 1-Amino-2,4-dibromoanthraquinone; and 2-Amino-5-chlorobenzophenone | kg | Free | | 15.4￠/kg + 50% |
| 2922.39.10 | 00 | 2'-Aminoacetophenone; 3'-Aminoacetophenone; 1-Amino-4-bromo-2-methylanthraquinone; 1,4-Bis[1-anthraquinonylamino]anthra- quinone; 1,4-Dimesidinoanthraquinone; 4-Dimethylaminobenzaldehyde; and Iminodianthraquinone | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 15.4￠/kg + 39% |
| 2922.39.14 | 00 | 2-Aminoanthraquinone | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P) 2.9% (SG) | 15.4￠/kg + 50% |
| 2922.39.17 | 00 | 1-Aminoanthraquinone | kg | Free | | 15.4￠/kg + 50% |
| 2922.41.00 | | Amino-acids, other than those containing more than one kind of oxygen function, and their esters; salts thereof: | | | | |
| 2922.41.00 | 10 | Meeting requirements of Food Chemical Codex, Codex Alimentarius or United States Pharmacopeia | kg | | | |
| 2922.43 | | Anthranilic acid and its salts: | | | | |
| 2922.49.10 | 00 | m-Aminobenzoic acid, technical; p-Aminobenzoic acid; 3,5-Diaminobenzoic acid; 2-Ethylamino-5-sulfobenzoic acid; 3-(N-Ethylanilino)propionic acid, methyl ester; β-( β-Methoxyethoxyethyl)-4-aminobenzoate; Methyl anthranilate; and l-Phenylalanine | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 39% |
| 2922.50.17 | 00 | Dermatological agents and local anesthetics | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 51.5% |
| 2923.20.10 | 00 | Purified egg phospholipids, pharmaceutical grade meeting requirements of the U.S. Food and Drug Administration, for use in intravenous fat emulsion | kg | Free | | 16.5￠/kg + 30% |
| 2924.23.10 | 00 | 2-Acetamidobenzoic acid (N-acetylanthranilic acid) and its salts: | | | | |
| 2924.29.20 | 00 | 2-Acetamido-3-chloroanthraquinone; o-Acetoacetanisidide; o-Acetoacetotoluidide; 2',4'-Acetoacetoxylidide; and 1-Amino-5-benzamidoanthraquinone | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 15.4￠/kg + 53% |
| 2924.29.31 | 00 | 4-Acetamido-2-aminophenol; p-Acetaminobenzaldehyde; Acetoacetbenzylamide; Acetoacet-5-chloro-2-toluidide; p-Acetoacetophenetidide; N-Acetyl-2,6-xylidine (N-Acetyl-2,6- dimethylaniline); p-Aminobenzoic acid isooctylamide; p-Aminobenzoylaminonaphthalenesulfonic acid; 2-Amino-4-chlorobenzamide; 3-Amino-4-chlorobenzamide; 4-Aminohippuric acid; p-Aminophenylurethane; 1-Benzamido-4-chloroanthraquinone; 1-Benzamido-5-chloroanthraquinone; Benzanilide; 4'-Chloroacetoacetanilide; 3-(N,N-Dihydroxyethylamino)benzanilide; 2,5-Dihydroxy-N-(2-hydroxyethyl)- benzamide; Gentisamide; N,N'-Hexamethylenebis(3,5-di-tert-butyl- 4-hydroxyhydrocinnamamide); 2-(m-Hydroxyanilino)acetamide; Nitra acid amide (1-Amino-9,10-dihydro-￠/(3-methoxypropyl)-4-nitro-9,10-dioxo-2- anthramide); Phenacetin, technical; and β-Resorcylamide | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 15.4￠/kg + 39.5% |
| 2925.29.10 | 00 | N'-(4-Chloro-o-tolyl)-N,N- diemthylformamidine; Bunamidine hydrochloride; and Pentamidine | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 41% |
| 2926.30 | | Fenproporex (INN) and its salts; Methadone (INN) intermediate (4-cyano-2-dimethylamino-4,4- diphenylbutane): | | | | |
| 2930.90.26 | 00 | 3-(4'-Aminobenzamido)phenyl-￠/hydroxy- ethylsulfone; 2-[(4-Aminophenyl)sulfonyl]ethanol, hydrogen sulfate ester; Diphenylthiourea; N,N'-(Dithiodi-2,1-phenylene)bisbenzamide; Pentachlorothiophenol; and 4,4'-Thiodiphenyl cyanate | kg | Free | | 15.4￠/kg + 40.5% |
| 2930.90.43 | 20 | Compounds containing a phosphorus atom to which is bonded one methyl, ethyl, n-propyl or isopropyl group, but no other carbon atoms | kg | | | |
| 2930.90.91 | 25 | Other compounds containing a phosphorus atom to which is bonded one methyl, ethyl, n-propyl or isopropyl group, but no other carbon atoms Other: | kg | | | |
| 2931.00.90 | 41 | Containing a phosphorus atom to which which is bonded one methyl, ethyl, n-propyl or isopropyl group, but no other carbon atoms | kg | | | |
| 2932.11.00 | 00 | Compounds containing an unfused furan ring (whether or not hydrogenated) in the structure: | | | | |
| 2932.99.39 | 00 | Benzointetrahydropyranyl ester; and Xanthen-9-one | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 15.4￠/kg + 39.5% |
| 2933.11.00 | 00 | Compounds containing an unfused pyrazole ring (whether or not hydrogenated) in the structure: | | | | |
| 2933.11.00 | 00 | Phenazone (Antipyrine) and its derivatives | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 15.4￠/kg + 49.5% |
| 2933.21.00 | 00 | Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure: | | | | |
| 2933.21.00 | 00 | Hydantoin and its derivatives | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 15.4￠/kg + 63% |
